Turn Therapeutics Slides 2.5% as Governance Updates Signal Stability
Turn Therapeutics shares dip 2.5% as the company’s latest SEC filings affirm strong governance and audit oversight, offering investors insight into its market resilience and future growth plans.
- TURN THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
4 minutes to read
